Internal Medicine, Hematology · Columbus, OH
NPI
1699962084
Since 2007
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
460 W 10th Ave Fl 5
Columbus, OH, 43210
Phone (614) 293-3196
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
364 services
Medicare patients, 2024
119
Average age 71
Drug cost, 2024
$6.5M
846 prescriptions
Company payments, 2025
$1,400
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alice S Mims was code 99214 (office e&m - established), 114 times for 58 patients. In total Alice S Mims billed 364 services in 14 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 114 | 58 | $70.37 | $8,022 |
| 99233 Hospital E&M - Subsequent | Facility | 88 | 25 | $89.65 | $7,889 |
| 99213 Office E&M - Established | Facility | 59 | 43 | $46.29 | $2,731 |
| 99215 Office E&M - Established | Facility | 43 | 24 | $109.03 | $4,688 |
| 99205 Office E&M - New | Facility | 11 | 11 | $137.36 | $1,511 |
By year: 2022 $28K for 380 services; 2023 $21K for 271 services; 2024 $28K for 364 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alice S Mims prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 78 prescriptions and refills. In total Alice S Mims wrote 846 Medicare prescriptions that cost $6.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jakafi Ruxolitinib Phosphate | 78 | 78 | Under 11 | $1.2M |
| Venclexta Venetoclax | 61 | 61 | 16 | $116K |
| Scemblix Asciminib Hydrochloride | 43 | 43 | Under 11 | $837K |
| Sprycel Dasatinib | 42 | 42 | Under 11 | $294K |
| Rezurock Belumosudil Mesylate | 34 | 34 | Under 11 | $853K |
| Oxycodone Hcl Generic | 32 | 32 | 13 | $400 |
| Acyclovir Generic | 31 | 39 | 12 | $537 |
| Inqovi Decitabine/Cedazuridine | 29 | 29 | Under 11 | $237K |
| Tasigna Nilotinib Hcl | 25 | 25 | Under 11 | $378K |
| Posaconazole Generic | 23 | 27 | Under 11 | $41K |
| Prednisone Generic | 19 | 21 | Under 11 | $90.4 |
| Bosulif Bosutinib | 18 | 18 | Under 11 | $290K |
| Idhifa Enasidenib Mesylate | 17 | 17 | Under 11 | $581K |
| Promacta Eltrombopag Olamine | 17 | 17 | Under 11 | $651K |
| Valacyclovir Valacyclovir Hcl | 17 | 23 | Under 11 | $261 |
Brand drugs: 436 claims; generic drugs: 410 claims; opioid claims: 43.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alice S Mims $1,400 ($1,400 in general payments such as food, travel and fees) from 1 company. The largest payer was Syndax Pharmaceuticals, Inc. with $1,400.
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. SNDX | 1 | $1,400 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.